Government Action/Industry Reaction: HHS Sees Success In Approach To Drug Pricing Solutions
Executive Summary
US HHS officials Azar and O’Brien tell a National Academy of Medicine forum that an important element of the Trump Administration’s approach to lowering drug prices is eliciting voluntary change from market players.